BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15368518)

  • 1. Epstein-Barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice.
    Padgett DA; Hotchkiss AK; Pyter LM; Nelson RJ; Yang E; Yeh PE; Litsky M; Williams M; Glaser R
    J Med Virol; 2004 Nov; 74(3):442-8. PubMed ID: 15368518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease.
    Glaser R; Litsky ML; Padgett DA; Baiocchi RA; Yang EV; Chen M; Yeh PE; Green-Church KB; Caligiuri MA; Williams MV
    Virology; 2006 Mar; 346(1):205-18. PubMed ID: 16321417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of viral and human dUTPase in Epstein-Barr virus-associated diseases.
    Fleischmann J; Kremmer E; Greenspan JS; Grässer FA; Niedobitek G
    J Med Virol; 2002 Dec; 68(4):568-73. PubMed ID: 12376965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV)-encoded dUTPase and chronic restraint induce impaired learning and memory and sickness responses.
    Aubrecht TG; Weil ZM; Ariza ME; Williams M; Reader BF; Glaser R; Sheridan JF; Nelson RJ
    Physiol Behav; 2014 Oct; 137():18-24. PubMed ID: 25034413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk.
    Waldman WJ; Williams MV; Lemeshow S; Binkley P; Guttridge D; Kiecolt-Glaser JK; Knight DA; Ladner KJ; Glaser R
    Brain Behav Immun; 2008 Feb; 22(2):215-23. PubMed ID: 17845840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
    Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
    J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of the Epstein-Barr virus-encoded dUTPase: patients with acute, reactivated or chronic virus infection develop antibodies against the enzyme.
    Sommer P; Kremmer E; Bier S; König S; Zalud P; Zeppezauer M; Jones JF; Mueller-Lantzsch N; Grässer FA
    J Gen Virol; 1996 Nov; 77 ( Pt 11)():2795-805. PubMed ID: 8922474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
    J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells.
    Ariza ME; Rivailler P; Glaser R; Chen M; Williams MV
    PLoS One; 2013; 8(7):e69827. PubMed ID: 23894549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
    J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
    J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.